| Jessica Wai Chung Young, OD | |
|
100 E California Blvd, Pasadena, CA 91105-3205 | |
| (800) 898-2020 | |
| Not Available |
| Full Name | Jessica Wai Chung Young |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 100 E California Blvd, Pasadena, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043565435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TUV007879 (New York) | Secondary |
| 152W00000X | Optometrist | 33903TLG (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Wai Chung Young, OD 100 E California Blvd, Pasadena, CA 91105-3205 Ph: (800) 898-2020 | Jessica Wai Chung Young, OD 100 E California Blvd, Pasadena, CA 91105-3205 Ph: (800) 898-2020 |
News Archive
A part of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA is highly conserved. Researchers have used this as a target for designing antisense oligonucleotide gapmers to cleave the RNA and disrupt virus replication. Their research is published as a preprint on the online server bioRxiv in September 2020.
ProAssurance Corporation and American Physicians Service Group, Inc. today announced they have entered into an agreement which calls for ProAssurance to acquire all the outstanding shares of American Physicians Service Group, Inc. in an all-cash transaction for $32.50 per share.
A previously shelved drug could prove effective for treating a group of rare childhood cancers, and Cancer Research UK today announced it has been granted exclusive marketing rights for the drug in these indications by the European Commission and the Food and Drug Administration (FDA).
Merrimack Pharmaceuticals, Inc. and Baxter International Inc. today jointly announced that Merrimack has completed the rolling submission of the New Drug Application (NDA) for MM-398 (irinotecan liposome injection), also known as "nal-IRI," to the U.S. Food and Drug Administration.
In an unexpected discovery, UCLA researchers have found that a gene previously known to control human metabolism also controls the equilibrium of bone and fat in bone marrow as well as how an adult stem cell expresses its final cell type.
› Verified 1 days ago
Dr. Mike V. Wong, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 80 N Lake Ave, Suite 102, Pasadena, CA 91101 Phone: 626-356-8088 Fax: 626-356-8078 | |
Dr. Barbara Jill Armstrong, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 | |
Tze Yu Tung, Optometrist Medicare: Medicare Enrolled Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 | |
Dr. Calvin Tan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 | |
Jessica Chang, OD Optometrist Medicare: Medicare Enrolled Practice Location: 477 E Colorado Blvd, Pasadena, CA 91101 Phone: 626-796-1191 Fax: 626-796-0189 | |
Accessoreyes Optometry Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 155 Cordova St, Unit 168, Pasadena, CA 91105 Phone: 626-577-8881 |